Phase II evaluation of gefitinib (ZD1839, IRESSA) in metastatic melanoma
Latest Information Update: 20 Jan 2006
At a glance
- Drugs Gefitinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 20 Jan 2006 New trial record.
Latest Information Update: 20 Jan 2006